Related Experiment Video
Updated: Jan 12, 2026
06:46
3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
Published on: February 25, 2022
2.3K
AI in steatohepatitis diagnostics: precision beyond the microscope
Ayesha Ejaz1, Mehreen Mushtaq Ahmed2, Maliha Khalid3
1Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Annals of Medicine and Surgery (2012)
|November 3, 2025
Summary
Artificial intelligence (AI) combined with digital pathology offers objective assessment for non-alcoholic steatohepatitis (NASH). This technology shows promise for improving diagnostic accuracy and patient care in liver disease.
Area of Science:
- Hepatology
- Digital Pathology
- Artificial Intelligence
Background:
- Non-alcoholic steatohepatitis (NASH) is a progressive liver disease with no cure.
- Current histological diagnosis of NASH faces challenges like variability and insensitivity.
Related Concept Videos
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
526
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
526
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176